- Home
- MRNA vs WSO Comparison
MRNA vs WSO Comparison
Compare MRNA & WSO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRNA
- WSO
- Stock Information
- Founded
- MRNA 2010
- WSO 1945
- Country
- MRNA United States
- WSO United States
- Employees
- MRNA N/A
- WSO N/A
- Industry
- MRNA Biotechnology: Biological Products (No Diagnostic Substances)
- WSO Industrial Machinery/Components
- Sector
- MRNA Health Care
- WSO Consumer Discretionary
- Exchange
- MRNA Nasdaq
- WSO Nasdaq
- Market Cap
- MRNA 16.0B
- WSO 19.1B
- IPO Year
- MRNA 2018
- WSO N/A
- Fundamental
- Price
- MRNA $35.53
- WSO $497.85
- Analyst Decision
- MRNA Hold
- WSO Buy
- Analyst Count
- MRNA 20
- WSO 4
- Target Price
- MRNA $59.65
- WSO $495.00
- AVG Volume (30 Days)
- MRNA 13.6M
- WSO 260.5K
- Earning Date
- MRNA 02-14-2025
- WSO 02-18-2025
- Dividend Yield
- MRNA N/A
- WSO 2.17%
- EPS Growth
- MRNA N/A
- WSO N/A
- EPS
- MRNA N/A
- WSO 13.30
- Revenue
- MRNA $3,236,000,000.00
- WSO $7,618,317,000.00
- Revenue This Year
- MRNA N/A
- WSO $4.49
- Revenue Next Year
- MRNA $21.39
- WSO $6.36
- P/E Ratio
- MRNA N/A
- WSO $37.49
- Revenue Growth
- MRNA N/A
- WSO 4.59
- 52 Week Low
- MRNA $29.25
- WSO $380.58
- 52 Week High
- MRNA $170.47
- WSO $571.42
- Technical
- Relative Strength Index (RSI)
- MRNA 48.60
- WSO 53.76
- Support Level
- MRNA $32.78
- WSO $461.45
- Resistance Level
- MRNA $36.98
- WSO $535.40
- Average True Range (ATR)
- MRNA 2.50
- WSO 12.39
- MACD
- MRNA 0.30
- WSO 4.47
- Stochastic Oscillator
- MRNA 66.81
- WSO 49.37
About MRNA Moderna Inc.
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 40 mRNA development candidates in clinical development as of September 2024. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
About WSO Watsco Inc.
Watsco is the largest heating, ventilation, air conditioning, and refrigeration products distributor in North America. The company primarily operates in the United States (90% of 2023 revenue) with significant exposure in the Sunbelt states. Watsco also has operations in Canada (5% of sales) and Latin America (5% of sales). The company's customer base consists of more than 125,000 contractors that serve the replacement and new construction HVACR markets for residential and light commercial applications.